Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Receivables (2021 - 2025)

Zymeworks' Receivables history spans 5 years, with the latest figure at $7.4 million for Q4 2025.

  • On a quarterly basis, Receivables fell 86.7% to $7.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.4 million, a 86.7% decrease, with the full-year FY2025 number at $7.4 million, down 86.7% from a year prior.
  • Receivables hit $7.4 million in Q4 2025 for Zymeworks, down from $30.3 million in the prior quarter.
  • Over the last five years, Receivables for ZYME hit a ceiling of $69.9 million in Q1 2023 and a floor of $3.2 million in Q2 2025.
  • Historically, Receivables has averaged $31.7 million across 5 years, with a median of $30.3 million in 2025.
  • Biggest five-year swings in Receivables: surged 591.54% in 2023 and later tumbled 90.03% in 2025.
  • Tracing ZYME's Receivables over 5 years: stood at $15.6 million in 2021, then soared by 133.12% to $36.4 million in 2022, then plummeted by 46.49% to $19.5 million in 2023, then skyrocketed by 187.08% to $55.9 million in 2024, then crashed by 86.7% to $7.4 million in 2025.
  • Business Quant data shows Receivables for ZYME at $7.4 million in Q4 2025, $30.3 million in Q3 2025, and $3.2 million in Q2 2025.